Anglikang (002940)
Overview
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, cardiovascular, urinary system (nephropathy), anesthesia and pain, and anti-androgen. The company was founded in 2001 and is based in Shengzhou, China.
Employees1275
Market Cap$7.1B
Revenue$1.4B
Listed OnShenzhen Stock Exchange
Ticker002940
CEOMr. Guo Gang Zheng
HeadquartersShengzhou